Previous Close | 0.1900 |
Open | 0.1950 |
Bid | 0.1950 x 0 |
Ask | 0.2000 x 0 |
Day's Range | 0.1950 - 0.1950 |
52 Week Range | 0.1500 - 0.2600 |
Volume | |
Avg. Volume | 11,603 |
Market Cap | 44.741M |
Beta (5Y Monthly) | -0.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
January 18, 2024 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field o...
Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field...
Toronto, Ontario - TheNewswire - October 10, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), an immune-oncology antibody-drug-conjugate company developing an innovative drug plat...